Skip to main content
. 2011 Jul 8;137(9):1317–1327. doi: 10.1007/s00432-011-1000-6

Table 2.

Outcome of patients with decreasing and increasing/highly variable numbers of CETC during maintenance therapy with trastuzumab or observation

Total Relapse Complete remission P
No trastuzumab
 Decrease 19 4 15 0.004
 Increase 9 7 2
Trastuzumab
 Decrease 25 1 24 <0.001
 Increase 11 7 4